Fierce Biotech
BrightGene’s oral dual agonist sees up to 8% weight loss at 8 weeks in slice of early data
China’s BrightGene has served up a slice of early-stage data to remind everyone that it has a horse in the oral obesity race.
China’s BrightGene has served up a slice of early-stage data to remind everyone that it has a horse in the oral obesity race.